Schizophrenia: all 3,539 studies
Page 32 of 36. Open to participants first (473), then studies with results posted, then the rest; newest registration first within each.
- Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese and Non-Japanese Female SubjectsCompletedNCT00458107Phase 1
- Peer Support for Increasing Physical Activity in People With Serious Mental IllnessesCompletedNCT00458094Not applicable
- Rapid Versus Conventional Titration of Quetiapine in Schizophrenia/Schizoaffective DisorderTerminatedNCT00457899Phase 3
- Efficacy of Selegiline in Negative Symptoms of SchizophreniaCompletedNCT00456976Early Phase 1
- Escitalopram in Schizophrenia in OCD- Open Label StudyCompletedNCT00456937Phase 4
- A Placebo-Controlled Single-Dose Trial of Sildenafil in SchizophreniaCompletedNCT00455715Phase 4
- Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)CompletedNCT00453804Phase 4
- Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)CompletedNCT00453609Phase 4
- Evaluation of Single and Repeat Doses of GSK729327 in Healthy VolunteersCompletedNCT00448890Phase 1
- Safety, PK and PD Study in Healthy Male Japanese SubjectsCompletedNCT00447941Phase 1
- Evaluation of the H1-coil Deep TMS in the Treatment of Negative Symptoms and Cognitive Deficit in SchizophreniaCompletedNCT00445926Phase 1
- Zyprexa and Task Engagement in SchizophreniaWithdrawnNCT00440843Phase 3
- Efficacy and Safety of AVE1625 as a Co-treatment With Antipsychotic Therapy in SchizophreniaTerminatedNCT00439634Phase 2
- Amisulpride in Schizophrenic Acute Phase PatientsCompletedNCT00436371Phase 4
- Families Coping With Mental Illness ProgramStatus unknownNCT00435721Phase 1
- Family-Directed Cognitive Adaptation Program for Individuals With SchizophreniaCompletedNCT00434980Not applicable
- Antipsychotic Medication Extended Dosing StudyCompletedNCT00431574Not applicable
- Brain Activation Patterns in Schizophrenia After Computerized Cognitive Skills TrainingCompletedNCT00431223Not applicable
- Work Activity Augmented by Cognitive Rehabilitation for SchizophreniaCompletedNCT00430560Phase 2/3
- Comparison of Video Consent Versus Routine Consent for Participation in Research StudiesCompletedNCT00430391Not applicable
- Study of Efficacy and Safety of Seroquel (Quetiapine Fumarate) as Mono-Therapy for Acute SchizophrenicCompletedNCT00428350Phase 4
- Org 24448 (Ampakine) for Cognitive Deficits in SchizophreniaWithdrawnNCT00425815Phase 2
- Shiatsu Adjuvant Therapy For SchizophreniaCompletedNCT00425399Not applicable
- Qualitative Analysis on the Experiences of Employment Among Schizophrenic PatientsCompletedNCT00423033
- Effects of Atomoxetine on Cognitive Function in SchizophreniaCompletedNCT00420498Phase 2
- Modulation of Regional Brain Activation in Schizophrenic Patients by Pharmacological TherapyTerminatedNCT00419653Phase 4
- Treatment of Schizophrenia With an Omega-3 Fatty Acid (EPA) and AntioxidantsCompletedNCT00419146Phase 2/3
- Association Between Schizophrenia and CancerCompletedNCT00419016
- Family Study in SchizophreniaStatus unknownNCT00418912
- Zotepine Versus Risperidone in Aggressive Schizophrenic Patients of Acute WardTerminatedNCT00418873Phase 4
- Large Simple Trial (LST) Of Cardiovascular Safety Of Ziprasidone And Olanzapine- (Zodiac)CompletedNCT00418171Phase 4
- An Evaluation of the Safety and Efficacy of ABT-925 in Subjects With Acute Exacerbation of SchizophreniaTerminatedNCT00412620Phase 2
- Effects Of The Drug Ketoconazole On How The Body Handles The Drug SB773812CompletedNCT00411866Phase 1
- Reboxetine Adjuvant Therapy for the Treatment of SchizophreniaStatus unknownNCT00409201Phase 1
- Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With SchizophreniaCompletedNCT00407277Not applicable
- Study Evaluating RGH-188 in the Treatment of Patients With SchizophreniaCompletedNCT00404573Phase 2
- Effect of High-Dose B-Complex Vitamins on the Symptoms of SchizophreniaCompletedNCT00403247Not applicable
- Efficacy Study of Panax Ginseng to Boost Antipsychotics Effects in SchizophreniaCompletedNCT00401089Phase 1/2
- Recovery Guide Intervention for Recurrent Psychiatric HospitalizationCompletedNCT00400166Not applicable
- PROFILe3: Epidemiologic Survey in Patients With Schizophrenia or Schizoaffective DisordersCompletedNCT00399334
- Indicated Prevention With Omega-3 Fatty Acids in Adolescents With 'At-Risk-Mental-State' for PsychosisCompletedNCT00396643Phase 4
- Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic PatientsTerminatedNCT00396214Phase 3
- Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of SchizophreniaStatus unknownNCT00395915Phase 4
- Effect of Ziprasidone on Glucose & Plasma Lipids in Diabetes (II) and Schizophrenia or Schizoaffective DisorderCompletedNCT00395031Phase 2/3
- A Study to Compare Two Different Brain Imaging Techniques in Healthy Volunteers and in Schizophrenic PatientsCompletedNCT00392743
- Supervised Treatment of Schizophrenia, a Randomized Controlled Trial.Status unknownNCT00392249Phase 1/2
- Attention Shaping Procedures for Improving Psychosocial Skills Among Adults With SchizophreniaCompletedNCT00391677Not applicable
- An Open-label Trial of Metformin for Weight Control of Pediatric Patients on Antipsychotic Medications.CompletedNCT00391261Phase 4
- Measuring Smoking Behavior in People With Schizophrenia and Bipolar DisorderCompletedNCT00382915
- Study Comparing the Affect of Bifeprunox Vs Olanzapine on Weight During the Treatment of Outpatients With Schizophrenia.CompletedNCT00380224Phase 3
- A Study Comparing Three Strategies to Switch Patients With Schizophrenia or Schizoaffective Disorder to Risperidone After Unsuccessful Treatment With Olanzapine.CompletedNCT00378183Phase 4
- A Follow-Up Study of Schizophrenic Participants Following Treatment Discontinuation After Remission From a First Psychotic EpisodeCompletedNCT00378092Phase 4
- Diabetes Screening, Risk Management and Disease Management in a High-Risk Mental Health Population Part IICompletedNCT00377117
- Niacin Flushing as Marker of Cannabis Effects on Arachidonic Acid Pathways in SchizophreniaCompletedNCT00376233
- Treatment of Refractory Schizophrenia With RiluzoleCompletedNCT00375050Not applicable
- Aripiprazole in the Treatment of Patients With Schizophrenia and Symptoms of Obsessive Compulsive Disorder (OCD)CompletedNCT00374348Not applicable
- The Effects of Nicotine Withdrawal on Reward Responsivity in SchizophreniaCompletedNCT00373126Phase 4
- L-Theanine in the Management of SchizophreniaCompletedNCT00372151Phase 3
- Quetiapine and the Dopaminergic Epigenetic ControlCompletedNCT00370500Phase 4
- Treatment With Risperidone Long Acting Injectable (RLAI) in an Early Phase of PsychosisCompletedNCT00369239Phase 4
- Study Comparing Bifeprunox to Risperidone in Treatment of Outpatients With Schizophrenia With Weight as Primary EndpointTerminatedNCT00366704Phase 3
- Study Evaluating Bifeprunox in Patients With Schizophrenia.TerminatedNCT00366327Phase 3
- Open Label Extension Study of BifeprunoxCompletedNCT00366171Phase 3
- SPECT Investigation Of The NMDA Receptor System In Healthy Volunteers And Patients With SchizophreniaTerminatedNCT00364429Phase 1
- Side Effects of Antipsychotic MedicationsCompletedNCT00363181
- Tetrabenazine for Partial RespondersCompletedNCT00362804Not applicable
- Selective Estrogen Receptor Modulators - A Potential Treatment for Psychotic Symptoms of SchizophreniaCompletedNCT00361543Phase 4
- Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and RisperidoneCompletedNCT00361166Phase 2
- Scale Validation Study for Prediction of Relapse and Short Term Rehospitalization in Patients With SchizophreniaCompletedNCT00358852
- Treating Psychotic Symptoms of Young Individuals Presenting a First Episode of Schizophrenia: Comparison of Two State-of-the-Art InterventionsCompletedNCT00358709Phase 3
- Culturally Based Family Therapy for Improving Treatment Outcome for People With SchizophreniaCompletedNCT00356317Phase 2
- The New Strategy for Pharmacological Treatment in People With SchizophreniaStatus unknownNCT00352339Phase 4
- Attention and Visual Perception in Schizophrenia: A Functional Magnetic Resonance Imaging (fMRI) StudyCompletedNCT00350935
- Cognitive Therapy for Negative Symptoms and FunctioningCompletedNCT00350883Phase 2
- Measuring Time Windows in Patients With Schizophrenia and Healthy ControlsCompletedNCT00350805
- A Randomized, Active-controlled, Double-blind, Parallel-Goup Study of the Efficacy and Safety of Extended Release(ER) Paliperidone in the Treatment of SchizophreniaCompletedNCT00350467Phase 3
- Switch Study of Existing Atypical Antipsychotics to BifeprunoxCompletedNCT00347425Phase 3
- Augmenting Clozapine With Sertindole - SERCLOZCompletedNCT00345982Not applicable
- Cognitive Training and Enhanced Supported Employment in SchizophreniaCompletedNCT00339170Not applicable
- Cognitive Behavioral Social Skills Training for Improving Social Functioning in People With SchizophreniaCompletedNCT00338975Not applicable
- Effectiveness of a Lifestyle Intervention for Increasing Physical Activity in Adults With SchizophreniaCompletedNCT00338832Phase 3
- Evaluation of Effectiveness and Safety of Paliperidone ER (Extended-release) Compared With Quetiapine in Patients With SchizophreniaCompletedNCT00334126Phase 3
- Antipsychotic Therapy and First EpisodeCompletedNCT00334035Phase 4
- Amisulpride in Schizophrenic PatientsCompletedNCT00331981Phase 4
- Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Acute Dystonia or ParkinsonismCompletedNCT00331825Phase 4
- Efficacy and Safety of Psychopharmacotherapy in Patients With Schizophrenia or Bipolar DisordersStatus unknownNCT00330226
- Effect on Cognitive Function of a Treatment With AripiprazoleCompletedNCT00329810Phase 4
- Seroquel STACK Study in Schizophrenic or Schizoaffective SubjectsCompletedNCT00328978Phase 3
- Changes in Auditory Verbal Hallucination During Atypical Antipsychotic Treatment of Patients With SchizophreniaCompletedNCT00328952
- Aripiprazole Augmentation for Clozapine-Treated Patients With Refractory SchizophreniaCompletedNCT00328367Phase 4
- Sarcosine (N-Methylglycine) Monotherapy for SchizophreniaCompletedNCT00328276Phase 2
- Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.CompletedNCT00325689Phase 4
- Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible TabletCompletedNCT00324051Phase 4
- Galantamine for Cognition in People With SchizophreniaCompletedNCT00320736Phase 4
- Nicotine Replacement Therapy for Smoking Cessation in SchizophreniaCompletedNCT00320723Phase 4
- Smoking Relapse Prevention in SchizophreniaCompletedNCT00320697Phase 4
- The Partners Genetics Collaborative Study of SchizophreniaCompletedNCT00319904
- A Study Using Rapid Acting Intramuscular Olanzapine in Agitated Patients With SchizophreniaCompletedNCT00316238Phase 2
- Risperidone-Induced Hyperprolactinemia Treated With BromocriptineStatus unknownNCT00315081Phase 3
- Modafinil as an Adjunctive on Cognitive Functioning in Patients With SchizophreniaCompletedNCT00314639Phase 1/2